Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Additional Help Sought From Congress By AHA And Hospitals

Getinge's New Torin Artificial Intelligence Solution Improves Hospital Efficiency

It doesn’t come as a surprise to learn that the American Hospital Association, as well as other hospital groups, have come forward and urged Congress for additional help as the cloud of the pandemic looms. In a letter addressed to the leader of Congress, Charles E. Schumer, and leaders Mitch McConnell and Kevin McCarthy, and Speaker Nancy Pelosi, the letter from the representatives of various healthcare associations and hospitals doesn’t look to mince words and asks for immediate relief as the pandemic isn’t showing any signs of halting. The representatives have asked for additional resources for member hospitals as all of them are consistently experiencing challenges, both operational and financial, that the new variants have had on them. As a note of appreciation towards the congress, the representatives have also thanked them for the aid that has been given till date and how it has proven to be useful for the front-liners and has even allowed healthcare centres and hospitals to keep providing quality care for patients as well as communities coming in at a critical time in the country’s history.

The letter states that as the country enters the third year of the pandemic, hospitals and their staff have already cared for more than 4 million COVID-19 inpatients. The patients’ severity at times has also risen, and it also boils down to the longevity of their stay as compared to the earlier part of the pandemic. The financial implications on the healthcare system, as per the representatives, have kept adding up. Citing an example, they said that delays in non-emergent cases continue with an ever increasing expense on medical supplies such as medicine, testing, and protective equipment.

In addition to this, there has been a mention of a worker shortage as well, which the hospitals have started to feel the heat of. When it comes to employment in the centres, it has seen a gradual decline from where it was pre-pandemic. Data by the Bureau of Labour Statistics has been put forth in the letter which states that employment across hospitals has seen a steep fall of 95,600 employees since the time the pandemic began in February 2020. The numbers include nurse shortages as well, who happen to be an integral part when it comes to patient care and management. To mitigate the effects of these manpower shortages, almost every hospital in the country, as per the representatives, has been forced to engage the services of temporary contract staff, which includes contract nurses too. This has given rise to many staffing agencies involved in providing nurses to exploit the situation by charging prices that are beyond imagination, two or even three times the regular price, to be exact.

As per Prolucent Health, if we look at a figure, there has been a whopping 67% rise in the pay rate of travel nurses in a matter of two years from January 2020 to January 2022. Besides this, the hospitals are billed another 28% to 32% by the staffing firms. As expected, the rate increase has proven unsustainable and has significantly increased labour costs.

In the letter, the representative also expressed gratitude to Congress for extending the moratorium on Medicare cuts, with reductions completely halted until April 1 and cuts reduced to 1% until June 30.The letter further calls for these measures to be extended with additional relief on the cuts even in 2022. The representatives have urged Congress to act now so that the hospitals and the entire system get the additional resources they require, including equipment and consistent supply, as well as balance out the staffing costs to continue caring for communities and patients.

Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment

Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment

Lumenis announced that it has partnered with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes. Ms. Moore suffered from dry eye disease and treatment with OptiLight significantly improved her condition. Now she’s partnering with Lumenis to share her story and empower others. She will star in OptiLight’s new campaign, showing millions of dry eye sufferers that they don’t have to “just live with it”.

Before she was diagnosed, Ms. Moore didn’t realize that her dry, itchy, burning eyes were actually signs of a condition called dry eye disease. Dry eye disease is remarkably common, affecting an estimated 49 million Americans, yet only half are diagnosed.1,2 To help dry eye sufferers like Ms. Moore, Lumenis, the world’s largest energy-based medical device company for eye care and aesthetics applications, recently launched OptiLight. This revolutionary, patented treatment is the first and only light-based therapy for dry eye disease. As part of a treatment regimen, OptiLight helps improve dry eye disease with a series of quick, gentle, in-office treatments.

“I’m excited to partner with Lumenis and share how OptiLight has made a real impact on my life. For years, I suffered from dry eye disease, but I didn’t know I had it! My eyes felt gritty and tired, and they looked red. I couldn’t wear my contact lenses for long. Eye drops didn’t do much. It was a constant frustration on the set and at home with my family,” said Ms. Moore. “When I learned that I had a medical condition called dry eye disease, I realized I didn’t have to just live with it—I could get a safe, effective treatment with OptiLight. Now, I can focus more time on what’s important to me, rather than battling the constant nuisance and discomfort of dry eye disease, and I want to inspire other people to say, ‘I won’t just live with it.’”

The “Not Gonna Live With It Generation” campaign featuring Ms. Moore debuted today with a commercial as well as a digital and print media campaign to encourage people to learn more about dry eye disease and find effective therapy with OptiLight.

“Lumenis is thrilled to partner with Mandy Moore for this important campaign, which will raise awareness of dry eye disease and introduce the groundbreaking treatment with OptiLight,” said Lumenis CEO Tzipi Ozer-Armon. “OptiLight with patented Optimal Pulse Technology (OPT) is the only light therapy for the management of dry eye disease. For millions of people who share Mandy’s experience with this condition, OptiLight is a perfect fit. Our ability to improve the quality of life for those who suffer from dry eye disease is why we do what we do, so it’s wonderful to see her enthusiasm for OptiLight and the results of her treatment. We hope it will inspire others to get better care for dry eye disease.”

About OptiLight

OptiLight™ is a light-based treatment that uses precise, intense broad-spectrum light to improve the signs of dry eye disease due to meibomian gland dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye, in patients 22 years of age and older with moderate to severe signs and symptoms of dry eye disease due to MGD and with Fitzpatrick skin types I-IV. OptiLight is to be applied only to skin on the malar region of the face, from tragus to tragus including the nose (eyes should be fully covered by protective eyewear). OptiLight is intended to be applied as an adjunct to other modalities, such as meibomian gland expression, artificial tear lubricants and warm compresses.

The treatment with OptiLight is not indicated for patients with certain medical conditions and carries risks, such as discomfort, damage to natural skin texture and change of skin pigmentation. Please ask your doctor if the OptiLight treatment is right for you.

About Lumenis

Lumenis is a leading energy-based medical device company for aesthetics and eye care applications in the area of minimally invasive clinical solutions. It is regarded as a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis’ groundbreaking products have redefined medical treatments and have set numerous technological and clinical gold standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods.

The Role of Technology in Tracking COVID-19

The Role of Technology in Tracking COVID-19

The world is fighting its battle with the deadly COVID-19, and with every passing month, a new and more dangerous variant of the virus emerges and threatens the safety of every human being.

Some have genetically inherited immunity against this disease, but we seem to be stuck in a vicious cycle of mutation. However, vaccines have proven to be the only defense to tackle these mutations and reduce the spread of COVID.

We can track and enforce mass vaccination drives with technological advancements and intelligent databases. That is where a vaccination tracker can prove to be valuable.

Detecting and isolating COVID-19 infections is a top goal for slowing the pandemic’s spread. A slew of applications have been created to assist users in reporting their symptoms and tracking the disease. Mobile technology provides a great tool to help with this endeavor through apps that gather user data. Here are some reasons why you should be using the app as well.

1. Track Your Symptoms

If you are tested positive, vaccine tracker apps help you to keep track of your symptoms and provide study-based information on what treatments to seek at each stage. That makes dealing with COVID less stressful and helps you treat your symptoms.

These apps also allow you to track your progress and promptly recognize any improvements or worsening of your situation. That helps you decide if your isolation is adequate or whether you require medical attention at a nearby hospital.

2. Store Your EU Digital COVID Certificate

We have seen travel restrictions becoming more strict, making it extremely important to carry your vaccination record. Airport security requires proof of vaccination, be it a domestic or international flight.

Vaccine tracking apps free you from the hassle of forgetting or losing your vaccination card with its e-vaccination card features. You can store your Digital Covid Certificate within your mobile app and access it anywhere, anytime.

3. Stay Up to Date With Employee Status

An app for tracking vaccines can connect with Human Resource (HR) Database allowing them to keep employees’ vaccination status updated. That helps HR segregate non-vaccinated individuals, enforce vaccination, and minimize the risk of workplace spread.

The apps can also inform people if they have been near someone who tested positive for COVID-19. This feature allows HR to quickly isolate at-risk people from everyone else, enabling the office to run smoothly without a complete shutdown after a new COVID case.

Endnote

Due to lack of awareness, not everyone is willing to be vaccinated, which causes a lot of distrust amongst people and threatens the safety of individuals. Some simple science experiments can help educate them about the spread of germs and viruses.

The advancements in technology have made life easier for both individuals and corporations alike. With the use of Apps for vaccine tracking, we will be better able to track and combat the never-ending covid outbreak and prevent COVID-related workplace liability lawsuits.

4 Tips For Finding The Best Adult Orthodontist

4 Tips For Finding The Best Adult Orthodontist

Your smile is one of your greatest assets, so it’s an excellent idea to invest in it. One of the easiest ways to keep your oral health in good condition is by practicing proper dental hygiene. This will help prevent any dental complications that may ruin your smile from happening.

However, some dental concerns like crooked teeth or an underbite can’t be solved by brushing and flossing alone. If you want to improve your dental condition, you need the assistance of an orthodontist.

But before you head to a dental clinic for a consultation, you should take note of the following points to find a suitable adult orthodontist who can assist you:

  1. Check Services Of Dental Clinics

If you’re looking for an orthodontist to help address your dental problem, the first thing you need to check is the services offered by their clinic. In some cases, dental clinics don’t offer all kinds of treatments and focus on specific procedures instead. For example, some dentists may specialize in treating children and adolescents as they’re more familiar with them.

So, it may help to ask a clinic you want to consult if they have an in-house orthodontist who conducts various dental procedures for adults. This way, it’ll be easier to schedule an examination and treatment for your concern.

You can check if an orthodontist performs procedures on adults by calling their office. You can tell them your concern and ask whether they offer services to fix it. Also, you can check the official site of the clinic you prefer to know more about their dental treatments. For instance, if you’re suffering from a misaligned bite, your orthodontist should know the best procedure to correct your dental problem.

  1. Ask For Recommendations

Dental health is an essential part of a person’s overall wellbeing, so it’s not uncommon for people to prioritize taking care of their teeth and gums. If you’re searching for an adult orthodontist to help you with your dental concerns, it may be an excellent idea to ask for recommendations from your friends or family. They may know someone who offers various orthodontic procedures for adults.

For instance, if you want to fix your teeth and know someone wearing braces to correct their smile, you may ask for their dentist’s information. It may be easier to book a consultation if you know the orthodontist you’ll call performs the same procedure you need.

When asking for recommendations from your peers, you can also ask them about their experience. Doing so will give you a better idea of what to expect once you visit the orthodontist. For example, if they have a positive and smooth experience with their dentist, it may signal that you’ll also be in good hands once you consult them.

  1. Find A Dental Clinic Near You

Unlike a regular dental check-up, an orthodontic procedure may require you to visit the dentist more often. For one, your orthodontist needs to check whether you’re making progress with your treatment and make adjustments to deliver the results you want. If the dental clinic you’ll go to is too far from your home, it may be difficult to keep up with your appointments. You may end up missing your check-ups and prolonging your treatment if you always need to go out of your way and travel just to see your dentist.

If you want to avoid this inconvenience, it may be a great idea to find an adult orthodontist near your area. This way, you can easily drop by the clinic whenever you have an appointment.

  1. Check The Costs

Some dental procedures cost a significant amount of money. For instance, getting customized retainers to prevent your teeth from adjusting may require you to shell out about USD$500-1000. So, if you’re searching for an orthodontist to fix your dental problem, you should check the price you’ll need to pay for the procedure you’ll receive.

You can check out a few orthodontic clinics and inquire about the average costs of their procedures. You can then compare the prices and inclusions so you can pick one that’ll suit your budget and needs.

If you have health insurance, it’s a good idea to check if it has dental coverage. You may get discounts for your orthodontic treatment if you use your health benefits.

Also, ask your dental clinic about their payment terms to check whether they offer flexible options. For instance, you can ask them if you can pay through monthly installments instead of a one-time payment if that method suits your budget better.

Final Thoughts

Asking for recommendations or going to a clinic within your area will help you find a suitable orthodontist. Also, reading reviews about your potential dentist will help you decide whether they can help resolve your dental concern.

WHO Says 90% Countries Healthcare Disrupted Due To COVID-19

As per the latest reports coming in from around the world, disruptions have been at their peak when it comes to health services that are basic like vaccination drives and disease treatment such as AIDS. These hurdles have been to the tune of 92% across 129 countries, as per the survey released by the WHO on the pandemic’s impact.

This survey, which was conducted in the final leg of 2021, i.e., in November and December, put out the fact that the services had been severely disrupted with very less or no improvement compared to the survey which took place in early 2021. The inference derived from the survey put out the fact that it was very important to address the challenges in the healthcare system, revive the existing services and also lessen the pandemic’s impact to a significant extent.

If we look at the figures, they look pretty worrying as ambulances and ER services, which are a part of emergency care, worsened, as 36% of countries reported severe disruptions, as against 29% in early 2021 and 21% in the first survey, which was conducted in 2020. Elective surgeries like hip and knee replacements were disrupted in 59% of the countries, and there were evident gaps in palliative as well as rehabilitative care, which were reported in almost half of them.

The timing of this survey coincided with the surging COVID cases in numerous countries in late 2021 because of highly transmissible Omicron, which in turn led to more strain on the healthcare system. The statement given by WHO signifies the scale of disruptions as against the already existing issues of health systems and demand for care, which is going down.

NAHSE and WittKieffer Form Strategic Partnership to Support the Development of Black Healthcare Leaders

NAHSE (the National Association of Health Services Executives) and WittKieffer announce that they have entered into a strategic partnership to further advance and develop Black healthcare leadership.

Both organizations go back more than 50 years in the healthcare industry. NAHSE is a non-profit association of Black health care executives founded in 1968 for the purpose of promoting the advancement and development of Black health care leaders, and elevating the quality of health care services rendered to minority and underserved communities. NAHSE’s purpose is to ensure greater participation of minority groups in the health field. Founded in 1969, WittKieffer is the most highly regarded executive search firm in healthcare. A key part of its mission is to support organizations that improve the quality of life and foster health equity, and to partner with like-minded organizations in advancing diversity in healthcare leadership.

NAHSE and WittKieffer have a longstanding relationship, with WittKieffer sponsoring and supporting NAHSE events and activities throughout the years. The current agreement is an opportunity to formalize the working partnership. As part of the collaboration, NAHSE and WittKieffer will team to provide career-related thought leadership for NAHSE members, special sessions at NAHSE’s annual educational conference and other key events, career counseling for members, and coordinated research on topics of importance to Black healthcare leaders.

“I am very excited about this strategic partnership between NAHSE and WittKieffer,” said Lisa Mallory, NAHSE Executive Director. “The two organizations’ histories are intertwined, and this will be an opportunity for us to write a new chapter together. The Black executives who are our members seek meaningful ways to develop their careers, and one way we can do this directly is by giving them access to the insight of top-notch executive search consultants like those at WittKieffer. NAHSE looks forward to exploring new ways in which we can work with WittKieffer for mutual benefit.”

“WittKieffer has long respected NAHSE and its mission of fostering Black leadership in healthcare and improving the care provided to underserved communities,” said Paul Bohne, managing partner and leader of WittKieffer’s Healthcare Practice. “Thanks in large part to NAHSE, Black executives have made tremendous strides in healthcare leadership. However, there is much progress yet to be made. We believe that our intentional, collaborative support of NAHSE will further open doors for Black leaders and continue to diversify the healthcare C-suite and managerial ranks. We thank NAHSE for this opportunity to join forces.”

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

Second Sight Medical Products, Inc. and Nano Precision Medical, Inc. announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and device medical implants that treat chronic diseases with high unmet medical need.

Nano Precision Medical, leveraging its proprietary NanoPortalTM drug implant technology, is creating a portfolio of new drugs that address medication non-adherence, a leading reason for poor clinical outcomes. The NanoPortal implant system combines innovative drug development, engineering and nanotechnology that can deliver minimally fluctuating drug release profiles across a wide range of small molecules, peptides, and monoclonal antibodies. NPM’s lead program, NPM-119, is a near clinical stage GLP-1 receptor agonist which is being developed to treat patients with Type 2 diabetes for up to 6 months with a single, tiny subdermal implant. Completion of non-clinical studies to support an Investigational New Drug Application (IND), filing the IND with the Food and Drug Administration and initiation of the First-in-Human clinical study, also known as the LIBERATE-1 trial, are anticipated by late 2022. Upon closing of the transaction, the combined company will be under the leadership of NPM’s co-founder, CEO and Chairman, Adam Mendelsohn, Ph.D.

According to Second Sight Chairman of the Board Gregg Williams, “The merger with NPM aligns with our expanded vision to become a top device and drug implant company, allows us immediate access to NPM’s experienced executive leadership team, and provides the two companies with a myriad of opportunities to leverage potential synergies.” NPM’s Dr. Adam Mendelsohn added, “At NPM we are very excited about the proposed merger with Second Sight, which will enable NPM to accelerate development activities for its internal pipeline and also engage with Second Sight in the continued exploration of their visual prosthesis business opportunity.”

In addition to advancing NPM’s drug implant portfolio, the company will continue to explore opportunities intended to create artificial forms of useful vision for the profoundly blind. Second Sight is currently developing the Orion® Visual Cortical Prosthesis System, an investigational device intended to bring artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma. Orion is currently being studied in an early feasibility study at UCLA and Baylor College of Medicine. Second Sight’s legacy product, the Argus® II, was approved by the FDA for the treatment of retinitis pigmentosa and was the world’s first FDA and CE Mark approved device that provides artificial vision to individuals with bare to no light perception. Since the Orion bypasses the optic nerve and directly stimulates the visual cortex of the brain, it has the potential to treat a much larger patient population than that associated with the Argus II.

Prior to the merger, Second Sight is providing NPM with $8 million for working capital and to enable acceleration of pipeline programs. The Boards of both companies voted to support the proposed merger agreement. If the proposed merger is consummated, Second Sight shareholders will join NPM shareholders, including AstraZeneca which has been a strategic investor in NPM since 2016. The parties anticipate completion of the merger in 2Q/3Q 2022.

ThinkEquity is serving as financial advisor to Second Sight in connection with the merger. In addition, the law firms of Venable and Golenbock are providing legal support for Second Sight and NPM, respectively.

About Second Sight Medical Products, Inc.

Second Sight Medical Products, Inc. develops implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals.

About Nano Precision Medical Products, Inc.

Nano Precision Medical. Inc is a privately held biopharmaceutical company developing drug implants by leveraging the company’s proprietary NanoPortal drug implant technology. These drug implants, designed to deliver minimally fluctuating drug profiles, will address drug non-adherence which is one of the top reasons for sub-optimal clinical benefit associated with oral and injectable products that treat chronic disease. The company’s lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The Company’s headquarters are in Emeryville, California.

Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest

LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation

Labcorp, a leading global life sciences company, announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.

The approximately 25,000-square-foot facility features expanded capabilities and new equipment for performing high-quality and efficient testing—creating more robust lab offerings for the community. The laboratory, which currently employs 100 individuals, will include STAT testing to expedite results for high-priority tests.

“This new lab offers increased capabilities for microbiology testing, allowing for a more flexible test menu that is tailored to fit the needs of our providers,” said Amy Rhine-Pallas, senior vice president of Labcorp’s North Central Division. “Ultimately, this leads to better patient diagnoses and outcomes. Our goal is to continue to invest in and provide the highest-quality service to patients and health care providers across the Midwest.”

Labcorp acquired the diagnostic clinical laboratory testing business of South Bend Medical Foundation in October 2019, considerably enhancing the scope of local services Labcorp offers to hospitals, physicians and patients across parts of Indiana, Michigan, Ohio and Illinois. The new laboratory further expands services to include northwestern Indiana and southern Michigan, and provides the communities in these areas with increased access and more efficient diagnostic testing solutions. In addition, the laboratory underscores Labcorp’s commitment to Indiana and builds on its strong operating presence in the state, which includes Labcorp Drug Development’s central laboratory and other facilities in Indianapolis.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020.

To Curb Omicron, Japan Calls For A Million Boosters A Day

Cerner Supporting Mass COVID-19 Vaccinations Around the World

Fumio Kishida, the Japanese Prime Minister, has recently gone on record to say that he is looking to speed up the country’s COVID-19 booster shots to 1 million a day by the end of February. This figure will be double the pace of what the country is currently doing as of now.

At a televised parliamentary meeting of the budget committee, Kishida said that he has instructed all his ministers to work with local authorities in order to speed up the inoculations as much as possible. Notably, the nationwide coronavirus infection surpassed 100,000 last Saturday for the first time. Most of the regions in Japan are under infection control measures to try to curb the Omicron variant, which has particularly spread in areas where fewer than 5% of the population have received the booster shots. Capital Tokyo and 12 out of the 47 prefectures in the country are on the verge of extending the virus curbs for another three weeks.

China Says Getting Normalcy In COVID-Zero Space Is No Option

China Says Getting Normalcy In COVID-Zero Space Is No Option

According to the researchers from China, the restoration of normalcy in mobility across COVID-zero regions in the country will cause around 2 million deaths a year, and the only way to control the virus is through the development of vaccines that offer a high level of efficacy, thereby preventing the infection from spreading. Notably, China’s zero-COVID restrictions have come under a lot of scrutiny in recent times as it is hosting the Winter Olympics in the national capital, while also using sweeping restrictions in order to prevent the omicron spread, which is more infectious.

Chinese officials, scientists, and public health specialists have put forth the fact that it is time to maintain stringent controls on the current situation since the transmission risk is very high and a mass infection scenario will put phenomenal pressure on the health system. The researchers have calculated the baseline efficacy of CoronaVac, the one used in Chile, and Pfizer and Oxford/AstraZeneca vaccines used in Britain.

Researchers have gathered from their findings that the baseline efficacy of the vaccines against the disease was 68.3% and against death, around 86%. The efficacy estimation for infection is based on data from Britain. On the other hand, efficacy against symptomatic disease as well as deaths is based on the Chilean data extracted from the CoronaVac study.

All said, with the global inoculation rate of 95%, if population mobility is restored to the 2019 levels, there is an estimation that all the COVID-zero regions will see infection numbers of more than 234 million in a year, which includes 64 million symptomatic cases and also 2 million deaths.

Chinese scientists in a paper published in the China Center for Disease Control and Prevention said that vaccine development must continue taking place and new ways should be explored to improve them so that the elimination of COVID-19 takes place at a global level. It is said in the published report that in order to reduce COVID to the level of an influenza post restoring mobility, the vaccine efficacy must be enhanced to 40% in cases of infection and 90% in cases of symptomatic disease.

Scientists have also come to the conclusion that it is more important that new vaccines be infection effective. The team has put forth an opinion that the key to controlling COVID lies in the development and effective as well as widespread use of efficient vaccines.

It should be noted that China is the only major country in the world that has maintained its zero-COVID policy despite repeated warnings that the move would harm its growth.Countries like Australia, New Zealand, and even Singapore have discontinued this strategy and are now sticking to the fact of learning to live with COVID.

China in recent times has doubled its “zero-COVID” message and consistently continues to seal off cities. The latest addition to the list is Baise in south Guangxi. Some athletes who are currently participating in the Winter Olympics have called the current steps excessive as they are being held in a closed loop bubble.

Wu Zunyou, who happens to be CCDC’s chief epidemiologist, tells Global Times that COVID-19 was initially thought as a virus that could be contained with vaccines, but he feels that there are no simple measures to contain it other than taking comprehensive measures.

Translate »